Tuoxin Pharmaceutical Group Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 831.98 million compared to CNY 777.81 million a year ago. Revenue was CNY 835.51 million compared to CNY 784.72 million a year ago.

Net income was CNY 243.07 million compared to CNY 286.54 million a year ago. Basic earnings per share from continuing operations was CNY 1.93 compared to CNY 2.27 a year ago. Diluted earnings per share from continuing operations was CNY 1.93 compared to CNY 2.27 a year ago.